Macroscopic visible core length can predict the histological sample quantity in endoscopic ultrasound-guided tissue acquisition: Multicenter prospective study.
core biopsy
endoscopic ultrasonography-guided fine needle biopsy
endoscopic ultrasonography-guided tissue acquisition
gross visual inspection
macroscopic on-site quality evaluation
Journal
Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society
ISSN: 1443-1661
Titre abrégé: Dig Endosc
Pays: Australia
ID NLM: 9101419
Informations de publication
Date de publication:
Mar 2022
Mar 2022
Historique:
revised:
10
08
2021
received:
27
03
2021
accepted:
25
08
2021
pubmed:
27
8
2021
medline:
17
3
2022
entrez:
26
8
2021
Statut:
ppublish
Résumé
Measurement of the macroscopic visible core (MVC) length during macroscopic on-site quality evaluation (MOSE) may allow estimation of sample adequacy for next-generation sequencing (NGS), and prediction of correct diagnosis in endoscopic ultrasound-guided tissue acquisition (EUS-TA) of pancreatic masses. This multicenter prospective study included consecutive patients who underwent EUS-TA for pancreatic masses using a 22-G Franseen needle. MVC length and pathological samples obtained from two needle passes were analyzed on a per-pass basis. Outcome measures included respective correlations of MVC length with histological sample quantity and diagnostic yields. The analysis included 204 passes from 102 EUS-TAs. MVC length correlated positively with histological sample quantity (P < 0.01). On the receiver operating characteristic curve for MVC length, the cut-off value and area under the curve for obtaining a candidate sample for NGS were 30 mm and 0.74 (95% confidence interval [CI] 0.65-0.83), respectively. On multivariate analysis, MVC length ≥30 mm was a significant factor affecting suitability for NGS (odds ratio 6.19; 95% CI 2.72-14.10). Histologic diagnostic yield correlated positively with MVC length (P = 0.01); however, there was no positive correlation between MVC length and overall (histology plus cytology) diagnostic yield. Measuring MVC length to predict histological sample quantity on MOSE may be of clinical significance during EUS-TA using a 22-G Franseen needle. It may be an effective method, particularly while submitting samples for NGS. University Hospital Medical Information Network Trials Registry (UMIN000036528).
Types de publication
Journal Article
Multicenter Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
622-631Informations de copyright
© 2021 Japan Gastroenterological Endoscopy Society.
Références
Polkowski M, Jenssen C, Kaye P et al. Technical aspects of endoscopic ultrasound (EUS)-guided sampling in gastroenterology: European Society of Gastrointestinal Endoscopy (ESGE) Technical Guideline-March 2017. Endoscopy 2017; 49: 989-1006.
Wani S, Muthusamy VR, Komanduri S. EUS-guided tissue acquisition: An evidence-based approach (with videos). Gastrointest Endosc 2014; 80: 939-59.
Yoshinaga S, Itoi T, Yamao K et al. Safety and efficacy of endoscopic ultrasound-guided fine needle aspiration for pancreatic masses: A prospective multicenter study. Dig Endosc 2020; 32: 114-26.
Ishiwatari H, Hayashi T, Kawakami H et al. Randomized trial comparing a side-port needle and standard needle for EUS-guided histology of pancreatic lesions. Gastrointest Endosc 2016; 84: 670-8.
Bang JY, Hebert-Magee S, Navaneethan U et al. Randomized trial comparing the Franseen and Fork-tip needles for EUS-guided fine-needle biopsy sampling of solid pancreatic mass lesions. Gastrointest Endosc 2018; 87: 1432-8.
Bang JY, Hebert-Magee S, Navaneethan U et al. EUS-guided fine needle biopsy of pancreatic masses can yield true histology. Gut 2018; 67: 2081-4.
Iwashita T, Yasuda I, Shimizu M. Endoscopic ultrasound-guided tissue acquisition: Can fork and crown cut the tissue? Dig Endosc 2019; 31: 146-7.
Bang JY, Kirtane S, Krall K et al. In memoriam: Fine-needle aspiration, birth: Fine-needle biopsy: The changing trend in endoscopic ultrasound-guided tissue acquisition. Dig Endosc 2019; 31: 197-202.
Fujie S, Ishiwatari H, Sasaki K et al. Comparison of the diagnostic yield of the standard 22-gauge needle and the new 20-gauge forward-bevel core biopsy needle for endoscopic ultrasound-guided tissue acquisition from pancreatic lesions. Gut Liver 2019; 13: 349-55.
Mita N, Iwashita T, Uemura S et al. Endoscopic ultrasound-guided fine needle biopsy using 22-gauge Franseen needle for the histological diagnosis of solid lesions: A multicenter prospective pilot study. Dig Dis Sci 2020; 65: 1155-63.
Nguyen YP, Maple JT, Zhang Q et al. Reliability of gross visual assessment of specimen adequacy during EUS-guided FNA of pancreatic masses. Gastrointest Endosc 2009; 69: 1264-70.
Ishiwatari H, Sato J, Fujie S et al. Gross visual inspection by endosonographers during endoscopic ultrasound-guided fine needle aspiration. Pancreatology 2019; 19: 191-5.
Iwashita T, Yasuda I, Mukai T et al. Macroscopic on-site quality evaluation of biopsy specimens to improve the diagnostic accuracy during EUS-guided FNA using a 19-gauge needle for solid lesions: A single-center prospective pilot study (MOSE study). Gastrointest Endosc 2015; 81: 177-85.
Sato J, Ishiwatari H, Sasaki K et al. Benefit of high negative pressure during endoscopic ultrasound-guided fine-needle aspiration with standard 22-gauge needles for pancreatic lesions: A retrospective comparative study. Scand J Gastroenterol 2019; 54: 108-13.
Feng M, Xiong G, Cao Z et al. PD-1/PD-L1 and immunotherapy for pancreatic cancer. Cancer Lett 2017; 407: 57-65.
Gao M, Lin M, Moffitt RA et al. Direct therapeutic targeting of immune checkpoint PD-1 in pancreatic cancer. Br J Cancer 2019; 120: 88-96.
Larson BK, Tuli R, Jamil LH et al. Utility of endoscopic ultrasound-guided biopsy for next-generation sequencing of pancreatic exocrine malignancies. Pancreas 2018; 47: 990-5.
Kaneko J, Ishiwatari H, Sasaki K et al. Macroscopic on-site evaluation of biopsy specimens for accurate pathological diagnosis during EUS-guided fine needle biopsy using 22-G Franseen needle. Endosc Ultrasound 2020; 9: 385-91.
Gerke H, Rizk MK, Vanderheyden AD et al. Randomized study comparing endoscopic ultrasound-guided Trucut biopsy and fine needle aspiration with high suction. Cytopathology 2010; 21: 44-51.
FoundationOne. FoundationOne Specimen Guidelines [Internet]. Cambridge: Foundation Medicine; 2017 [cited 2020 Nov 2]. Available from: https://www.foundationmedicineasia.com/content/dam/rfm/apac_v2-en/FOne_Specimen_Guidelines.pdf.
Wani S, Mullady D, Early DS et al. The clinical impact of immediate onsite cytopathology evaluation during endoscopic ultrasound-guided fine needle aspiration of pancreatic masses: A prospective multicenter randomized controlled trial. Am J Gastroenterol 2015; 110: 1429-39.
Lee LS, Nieto J, Watson RR et al. Randomized noninferiority trial comparing diagnostic yield of cytopathologist-guided versus 7 passes for EUS-FNA of pancreatic masses. Dig Endosc 2016; 28: 469-75.
van Riet PA, Cahen DL, Poley JW et al. Mapping international practice patterns in EUS-guided tissue sampling: Outcome of a global survey. Endosc Int Open 2016; 4: E360-70.